Navigation Links
CHPA Responds to Kentucky Senate Judiciary Passage of Senate Bill 3
Date:3/1/2012

WASHINGTON, March 1, 2012 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement after the Kentucky Senate Judiciary Committee passed Senate Bill 3, legislation that would impose significant restrictions on safe and effective medicines containing pseudoephedrine (PSE), such as Advil Cold & Sinus, Allegra-D, Claritin-D, Mucinex D, and Sudafed.  SB 3 would limit the amount of PSE consumers can buy to 15 grams a year and 3.6 grams a month. The measure now moves to the full Senate for consideration.  

"Severe restrictions on cold and allergy medicines containing pseudoephedrine will prevent chronic allergy suffers and many Kentucky families from accessing affordable, quality healthcare they rely upon," said Scott Melville, president and chief executive officer of the CHPA. "For thousands of Kentuckians—especially those who suffer from seasonal allergy symptoms—there's absolutely no difference between a prescription mandate and Senate Bill 3, especially given the fact that the Commonwealth of Kentucky has one of the longest allergy seasons in the country. The significant gram limit called for in SB 3 would lead to involuntary time off work, lost wages and increased health expenses for many responsible Kentucky families and workers."

"Kentucky Senators made the right decision when they shut the door on SB 50 last week. We are hopeful that the Kentucky Senate will listen to their constituents and enact anti-meth policies that target criminals without burdening responsible workers and families with additional barriers to these legal medicines."

www.chpa-info.org

CHPA is the 131-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. CHPA Responds to Prescription Mandate Cost Implications Outlined in Oklahoma Economic Impact Study
2. Questcor Pharmaceuticals Responds to Questions From Investor Blog
3. AVMA Responds to Federal Order Limiting Use of Antibiotics In Food Animals
4. Ampio Responds to Recent Publications by Anonymous Short Sellers
5. Nationwide Coalition Responds to Express Scripts CEO Statement: "I Cant Stop Certain Pharmacies From Going Out of Business"
6. China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group
7. International Academy of Compounding Pharmacists (IACP) Responds to FDAs Appeal of the U.S. District Court Ruling on Pharmacy Compounding
8. Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimers Patent Application
9. NeuroSigma Responds to Substantial Interest Generated by NPR Story on Promising Epilepsy Clinical Trial
10. Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis
11. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Inc. (NASDAQ: IONS ), the leader in antisense therapeutics, ... BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December ... A live webcast of the presentation will be available on the ... be available within 48 hours and will be archived for a ... , , ...
(Date:12/7/2016)... Inc. (NYSE: LCI ) today announced that the company ... Healthcare Conference on December 14, 2016 at 9:20 a.m. (ET) at ... . In addition, the company will host one-on-one meetings ... Annual Boston Healthcare Conference taking place on December 13, 2016 at ... , ...
(Date:12/6/2016)... 2016  Alopexx Oncology, LLC announced data from a ... protein (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal ... B cells as Rituxan and maintains the activities of ... involved in tumor targeting, engagement of the immune system, ... of the study (abstract #95954) were presented at the ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. Edward Hallowell, host of ... media that offer a rare glimpse into the mind of those people with ADHD. ... Times bestselling author, has described people with ADHD as having “Ferrari engines for a ...
(Date:12/7/2016)... MI (PRWEB) , ... December 07, 2016 , ... ... and financial consultation services from offices located in South Lyon, Dewitt, Williamston, East ... benefit a basketball coach who needs treatment for a brain tumor. , Jason ...
(Date:12/7/2016)... ... , ... A. Kevin Spann Insurance, a New York-based firm offering insurance and ... a charity drive to raise funds that will benefit the Marine Corps League. , ... Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans ...
(Date:12/7/2016)... Phoenix, Arizona (PRWEB) , ... December 07, 2016 , ... ... Juvederm®, Just in Time For The Holiday Party Season. Save Up To 33% Off ... and Laser Salon is providing the Phoenix Valley with Delightful Deals on ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... Business Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on ... user experience. , BOC Global Events & Training Group is a professional event ...
Breaking Medicine News(10 mins):